Rifaximin, but not growth factor 1, reduces brain edema in cirrhotic rats

Figure 3 Ammonia response to oral glutamine-challenge tests. The area under the curve (AUC) was significantly increased by both placebo and insulin-like growth factor (IGF)-1-treatment in cirrhotic rats. By contrast, the AUC in rifaximin-treated cirrhotic rats was similar to that observed in controls. Cirr: Cirrhosis; Cont: Control; R: Rifaximin.